1. Home
  2. IPSC

IPSC

Century Therapeutics Inc.

Logo Century Therapeutics Inc.

Health Care

Medicinal Chemicals and Botanical Products

Nasdaq

as 04-19-2024 4:00pm EST

$
-
.
-
-
+$
-
.
-
-
+
-
.
-
-
%

Century Therapeutics Inc is a biotechnology company specializes in leveraging adult stem cells to develop advanced cell therapy products targeting cancer, autoimmune, and inflammatory diseases. Their innovative approach involves a genetically engineered allogeneic cell therapy platform comprising induced pluripotent stem cells (iPSCs), CRISPR-mediated precision gene editing, proprietary chimeric antigen receptors (CARs), Allo-EvasionTM technology, and cutting-edge manufacturing capabilities. This comprehensive platform aims to overcome the limitations of first-generation cell therapies by optimizing cell product performance, preventing rejection by the host immune system, and minimizing development and supply risks.

Founded: 2019 Country:
United States
United States
Employees: N/A City: PHILADELPHIA
Market Cap: 200.3M IPO Year: 2021
Target Price: $14.00 AVG Volume (30 days): 219.0K
Analyst Decision: Strong Buy Number of Analysts: 6
Dividend Yield: N/A Dividend Payout Frequency: N/A
EPS: -2.30 EPS Growth: N/A
52 Week Low/High: $1.28 - $5.51 Next Earning Date: 05-09-2024
Revenue: $2,235,000 Revenue Growth: -57.01%
Revenue Growth (this year): 174.41% Revenue Growth (next year): 228.89%

Share on Social Networks: